Filing Details
- Accession Number:
- 0001181431-12-014029
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-03-02 19:09:11
- Reporting Period:
- 2012-02-24
- Filing Date:
- 2012-03-02
- Accepted Time:
- 2012-03-02 19:09:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1325879 | Aveo Pharmaceuticals Inc | AVEO | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1486359 | Jeno Gyuris | C/O Aveo Pharmaceuticals, Inc. 75 Sidney Street Cambridge MA 02139 | Svp, Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2012-02-29 | 1,000 | $13.18 | 90,612 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-03-01 | 2,000 | $13.33 | 88,612 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-03-02 | 2,100 | $13.16 | 86,512 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $13.10 to $13.25 per share. The reporting person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $13.32 to $13.34 per share. The reporting person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $13.16 to $13.20 per share. The reporting person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
